Xiaojing Xu, Yiyi Yu, Tianshu Liu, Minzhi Lv, Hangyu Zhang, Luoyan Ai, Yuehong Cui, Xi Tang, Hong Zong, Qing Xu, Rongbo Lin, Siyu Chen. "Tislelizumab plus cetuximab and irinotecan in relapsed/refractory RAS/BRAF wild-type and microsatellite stable metastatic colorectal cancer: A randomized, controlled, multicenter study (TEC2).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.3530